Search - tctmd.com

Displaying 21 - 40 of 116

Sort: Relevancy | Date

Presentation THT 2025

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

Presenter: Matteo Pagnesi

February 12, 2025

Presentation THT 2025

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Presenter: Akshay Desai

February 12, 2025

Presentation THT 2025

Clinical Trial Updates: What's New? What's Coming?

Presenter: Jay Giri

February 12, 2025

Presentation THT 2025

When to Use a Noninvasive Device That Remove Fluid From the Extracellular Space

Presenter: Daniel Bensimhon

February 12, 2025

Presentation THT 2025

When to Use a Form of Replacement Therapies

Presenter: Maria Rosa Costanzo

February 12, 2025

Presentation THT 2025

When to Use an Invasive Device That Removes Fluid From the Extracellular Space

Presenter: William Abraham

February 12, 2025

Presentation THT 2025

When to Use Devices the Recude Renal Vein Pressure

Presenter: Liviu Klein

February 12, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Presenter: Beth Davison

February 12, 2025

Presentation THT 2025

Congestion in Heart Failure: How Aggressive Should We Be to Dry Patients Out

Presenter: G. Michael Felker

February 12, 2025

Presentation THT 2025

When and Why Are Diuretics Sometimes Just Not Enough?

Presenter: Jennifer Cowger

February 12, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Presenter: James Udelson

February 11, 2025

Presentation THT 2025

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Presenter: Gregg W. Stone

February 11, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Presenter: Allan Böhm

February 11, 2025

Presentation THT 2025

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Presenter: Mahir Karakas

February 11, 2025

Presentation THT 2025

Harnessing Real World Data to Test Emerging Technologies

Presenter: Robert Yeh

February 11, 2025

Presentation THT 2025

Time to Escalation: From the Golden Day to the Golden Six Hours

Presenter: Elric Zweck

February 11, 2025

Presentation THT 2025

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Presenter: Shelley Hall

February 11, 2025

Advertisement

Burst Steroid Therapy and Quality of Life in Patients With Acute Heart Failure: Insights From the CORTAHF Trial

A Digital Platform to Optimize Guideline Directed Heart Failure Therapy: Primary Results of the AIM-POWER Randomized Controlled Trial

Clinical Trial Updates: What's New? What's Coming?

When to Use a Noninvasive Device That Remove Fluid From the Extracellular Space

When to Use a Form of Replacement Therapies

When to Use an Invasive Device That Removes Fluid From the Extracellular Space

When to Use Devices the Recude Renal Vein Pressure

Special Late-Breaking Clinical Science Abstract: Effects of Anti-Inflammatory Therapy in Acute Heart Failure: A Systematic Review and Meta-Analysis

Congestion in Heart Failure: How Aggressive Should We Be to Dry Patients Out

When and Why Are Diuretics Sometimes Just Not Enough?

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Predictors of Outcomes After Inter-atrial Shunt Treatment in HFrEF and HFpEF: The RELIEVE-HF trial

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Harnessing Real World Data to Test Emerging Technologies

Time to Escalation: From the Golden Day to the Golden Six Hours

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content